Completed PHASE4 INTERVENTIONAL 2-arm NCT00603083

Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia

Postoperative Pain Treatment in Total Hip Arthroplasty A Randomized Double-blinded Placebo-controlled Study to Assess the Effect of Local Analgesia

Sponsor: Vejle Hospital

Conditions Pain, Postoperative

Interventions Placebo Ropivacaine, Ketorolac and Adrenalin

Updated 6 times since 2017 Last updated: Dec 8, 2011 Started: Jan 31, 2008 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00603083, this PHASE4 trial focuses on Pain, Postoperative and remains completed. Sponsored by Vejle Hospital, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vejle Hospital

Data source: Vejle Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vejle, Denmark